Harmony Biosciences Holdings Inc (HRMY)
34.07
+0.84
(+2.53%)
USD |
NASDAQ |
Nov 22, 16:00
34.07
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Net Income (Quarterly): 46.09M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 46.09M |
June 30, 2024 | 11.59M |
March 31, 2024 | 38.33M |
December 31, 2023 | 26.61M |
September 30, 2023 | 38.46M |
June 30, 2023 | 34.30M |
March 31, 2023 | 29.48M |
December 31, 2022 | 48.51M |
September 30, 2022 | 87.94M |
June 30, 2022 | 23.53M |
March 31, 2022 | 21.48M |
December 31, 2021 | 22.71M |
Date | Value |
---|---|
September 30, 2021 | -9.62M |
June 30, 2021 | 14.12M |
March 31, 2021 | 7.386M |
December 31, 2020 | -0.208M |
September 30, 2020 | 1.909M |
June 30, 2020 | -0.027M |
March 31, 2020 | -38.62M |
December 31, 2019 | -36.44M |
September 30, 2019 | -31.90M |
June 30, 2019 | -20.62M |
March 31, 2019 | -63.02M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-38.62M
Minimum
Mar 2020
87.94M
Maximum
Sep 2022
18.38M
Average
22.10M
Median
Net Income (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 1.341B |
Incyte Corp | 106.46M |
EyePoint Pharmaceuticals Inc | -29.36M |
Cassava Sciences Inc | -27.94M |
Capricor Therapeutics Inc | -12.56M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 186.04M |
Total Expenses (Quarterly) | 124.33M |
EPS Diluted (Quarterly) | 0.79 |
Enterprise Value | 1.715B |
Gross Profit Margin (Quarterly) | 77.01% |
Profit Margin (Quarterly) | 24.78% |
Earnings Yield | 6.19% |
Operating Earnings Yield | 8.87% |
Normalized Earnings Yield | 6.193 |